ArteriA Medical Science

ArteriA Medical Science researches and develops products for the diagnosis, prevention, and treatment of cardiac stroke. The company has developed the Parodi Anti-Embolism System (PAES), which prevents cerebral embolism during angioplasty and stent placement. ArteriA Medical Science was founded in 1998 and is headquartered in San Francisco, California.